| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Processa Pharmaceuticals Inc (NASDAQ: PCSA)
PCSA Technical Analysis
5
| As on 17th Dec 2025 PCSA SHARE Price closed @ 6.68 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.42 & Strong Buy for SHORT-TERM with Stoploss of 0.84 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PCSASHARE Price
| Open | 3.28 | Change | Price | % |
| High | 8.88 | 1 Day | 6.56 | 5466.67 |
| Low | 3.28 | 1 Week | 6.40 | 2285.71 |
| Close | 6.68 | 1 Month | 6.33 | 1808.57 |
| Volume | 39061701 | 1 Year | 5.52 | 475.86 |
| 52 Week High 6.68 | 52 Week Low 0.12 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| VYNE | 0.60 | 50.00% |
| NVDA | 170.94 | -3.81% |
| LMDX | 0.02 | 0.00% |
| YGMZ | 0.02 | -66.67% |
| IRBT | 0.76 | 0.00% |
| TSLA | 467.26 | -4.62% |
| AKTS | 0.04 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| PCSA Daily Charts |
PCSA Intraday Charts |
Whats New @ Bazaartrend |
PCSA Free Analysis |
|
|
PCSA Important Levels Intraday
| RESISTANCE | 17.47 |
| RESISTANCE | 14.01 |
| RESISTANCE | 11.87 |
| RESISTANCE | 9.73 |
| SUPPORT | 3.63 |
| SUPPORT | 1.49 |
| SUPPORT | -0.65 |
| SUPPORT | -4.11 |
PCSA Forecast December 2025
| 4th UP Forecast | 7.86 |
| 3rd UP Forecast | 7.48 |
| 2nd UP Forecast | 7.25 |
| 1st UP Forecast | 7.01 |
| 1st DOWN Forecast | 6.35 |
| 2nd DOWN Forecast | 6.11 |
| 3rd DOWN Forecast | 5.88 |
| 4th DOWN Forecast | 5.5 |
PCSA Weekly Forecast
| 4th UP Forecast | 7.70 |
| 3rd UP Forecast | 7.37 |
| 2nd UP Forecast | 7.17 |
| 1st UP Forecast | 6.97 |
| 1st DOWN Forecast | 6.39 |
| 2nd DOWN Forecast | 6.19 |
| 3rd DOWN Forecast | 5.99 |
| 4th DOWN Forecast | 5.66 |
PCSA Forecast2025
| 4th UP Forecast | 23.58 |
| 3rd UP Forecast | 18.16 |
| 2nd UP Forecast | 14.81 |
| 1st UP Forecast | 11.46 |
| 1st DOWN Forecast | 1.9 |
| 2nd DOWN Forecast | -1.45 |
| 3rd DOWN Forecast | -4.8 |
| 4th DOWN Forecast | -10.22 |
Processa Pharmaceuticals Inc ( NASDAQ USA Symbol : PCSA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PCSA Business Profile
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase II clinical trials for the treatment of necrobiosis lipoidica, a chronic disfiguring condition. The company is also developing PCS12852, a novel selective 5-hydroxytryptamine 4 (5-HT4) receptor agonist that is in Phase II clinical trials for the treatment of gastroparesis; and PCS6422, an oral, potent, selective, and irreversible inhibitor that is in Phase I clinical trials for treating metastatic colorectal and breast cancer. It has a license agreement with Akashi Therapeutics, Inc. to develop and commercialize PCS100, an anti-fibrotic and anti-inflammatory drug. The company was incorporated in 2011 and is based in Hanover, Maryland. Address: 7380 Coca Cola Drive, Hanover, MD, United States, 21076
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service